Thomas John Dietz Insider Trading $EIGR Eiger BioPharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas John Dietz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas John Dietz. Thomas John Dietz is Director in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and Director in LEAP THERAPEUTICS, INC. ($LPTX).
Thomas John Dietz in Eiger BioPharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas John Dietz: Director
Holdings: 36,500 shares
Current Value: $423,400
Latest Transaction: Apr 12 2021
$EIGR Market Capitalization: $93.59M
$EIGR Previous Close: $11.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Thomas John Dietz in Eiger BioPharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EIGR, LPTX, PRTK
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 8.50 | 1,000 | 8,500 | 37,500 | 36.5 K to 37.5 K (+2.74 %) |
| Apr 12 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 8.48 | 1,500 | 12,720 | 36,500 | 35 K to 36.5 K (+4.29 %) |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 9.99 | 20,000 | 199,800 | 20,000 | |
| Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Grant | A | 0.00 | 5,000 | 0 | 35,000 | 30 K to 35 K (+16.67 %) |
| Mar 17 2020 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 4.95 | 1,000 | 4,950 | 30,000 | 29 K to 30 K (+3.45 %) |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 5.60 | 20,000 | 112,000 | 20,000 | |
| Mar 13 2020 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Grant | A | 0.00 | 5,000 | 0 | 29,000 | 24 K to 29 K (+20.83 %) |
| Jan 13 2020 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 13.94 | 4,000 | 55,760 | 24,000 | 20 K to 24 K (+20.00 %) |
| Apr 23 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 11.10 | 5,000 | 55,495 | 20,000 | 15 K to 20 K (+33.33 %) |
| Apr 22 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 11.05 | 5,000 | 55,250 | 15,000 | 10 K to 15 K (+50.00 %) |
| Apr 22 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 11.05 | 5,000 | 55,250 | 15,000 | 10 K to 15 K (+50.00 %) |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 13.41 | 20,000 | 268,200 | 20,000 | |
| Mar 25 2019 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 13.41 | 20,000 | 268,200 | 20,000 | |
| Dec 20 2018 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 9.98 | 5,000 | 49,900 | 10,000 | 5 K to 10 K (+100.00 %) |
| Dec 10 2018 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Buy | P | 11.26 | 5,000 | 56,300 | 5,000 | 0 to 5 K |
| Mar 16 2018 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 9.50 | 10,000 | 95,000 | 10,000 | |
| Apr 13 2017 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 8.50 | 10,000 | 85,000 | 10,000 | |
| Apr 01 2016 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 15.75 | 23,000 | 362,250 | 23,000 | |
| Apr 01 2016 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 15.75 | 25,000 | 393,750 | 25,000 |
Page: 1